Utility of adaptive servoventilation device software in assessing residual respiratory events in the treatment of central apneas
Autor: | Patricia Lloberes, Odile Romero, María Guadalupe Silveira, Roser Cambrodi, Gabriel Sampol, Alex Ferré, María José Jurado |
---|---|
Rok vydání: | 2016 |
Předmět: |
medicine.medical_specialty
animal structures medicine.diagnostic_test business.industry Adaptive servo ventilation Central apnea Limits of agreement Polysomnography Residual nervous system diseases respiratory tract diseases stomatognathic system Apnea–hypopnea index Internal medicine embryonic structures Cardiology Medicine In patient Respiratory system business |
Zdroj: | 4.2 Sleep and Control of Breathing. |
Popis: | Background: The utility of the device software in assessing residual apnea hypopnea index (AHI) on adaptative servoventilation (ASV) treatment has not been evaluated. Objectives: To assess the precision of the smart card device in assessing residual AHI in patients treated with ASV. Methods: Seven patients with central apneas (CA) and 9 patients with complex sleep apnea (CompSA) were offered ASV. A 3 months polysomnography (PSG) with the patient9s device was performed and the AHI recorded on the ASV smart card (ASV-AHI) was compared to the physician recorded PSG-AHI. Results: median baseline AHI was 50 (p25th-75th 48-81) with a central apnea index (CAI) of 37 (p25th-75th 22-57) in CA patients, and 46 (p25th-75th 41.5-60.5) with a CAI of 44 (p25th-75th 19-54.5) in CompSA patients. Two patients refused treatment, 3 used BiPAP autoSV Advanced and 11 AutoSet CS. The mean difference between PSG-AHI and ASV-AHI was 11.9 ± 9.6 (95% limits of agreement -6.90, 30.71), mostly representative of underscoring hypopneas, to a greater extent at a higher residual AHI. According to ASV device software, ASV correctly treated (AHI Conclusions: ASV device software underestimated residual AHI compared to manual scoring of PSG to a greater extent at a higher residual AHI. |
Databáze: | OpenAIRE |
Externí odkaz: |